UCB

Shareholders are invited to participate in the Ordinary General Meeting (the “General Meeting”) to be held on Thursday, 24 April 2025, at 11:00 AM CEST, at the registered office of UCB SA/NV, Allée de la Recherche 60 - 1070 Brussels.

At UCB, we innovate to deliver unique outcomes that help patients achieve their life goals, ensure access for those who need our solutions, and create the best individual experience for them in a way which is viable for society, our investors and UCB.
Over 90 years of innovation has made us who we are today. Decades of scientific excellence have seen us launch life-changing medicines and develop expertise. We built momentum through pioneering research and evolving science and technology, ensuring we can discover and develop new medicines effectively and build on our existing strengths.

Find all documents related to the meeting on the webpage.

Via this link you can view the registration instructions.